Team: No. 16 Drive Down A1C Lilly Diabetes Ford Mustang
Crew Chief: Phil Gould
Twitter: @driverRyanReed, @Reed16Team and @RoushFenway
ADVANCE NOTES
Reed at Texas
Ryan Reed will make his 10th NASCAR Xfinity Series start at Texas Motor Speedway this weekend. In his nine previous starts at the 1.5-mile track, Reed has finished 23rd or above and has six top-15 finishes.
Reed has an average starting position of 12 and an average finishing position of 15.7 at Texas Motor Speedway.
Texas Spring 2018
Ryan Reed started the race from Texas Motor Speedway in the fourth position under chilly 34 degree temperatures and had a fast Lilly Diabetes Drive Down A1C Ford Mustang right from the start. A pit road penalty late in the race cost him valuable track position, but Reed rebounded to earn a 14th-place finish.
Walk with Reed
Fans with pre-race passes can join Ryan for the NASCAR Fitness Challenge Fan Lap Powered by Lilly Diabetes track walk Sunday morning at 10:30am.
www.DriveDownA1C.com
Ryan Reed and Lilly Diabetes are encouraging and motivating NASCAR fans to better manage their diabetes by visiting www.DriveDownA1C.com to learn more about resources and treatment options.
Did You Know?
Ryan Reed was diagnosed at the age of 17 with Type 1 Diabetes. Through hard work, perseverance and working with his doctors he’s been able to manage his diabetes and set an example to others.
Reed on Texas
“Texas is so unique. There isn’t another corner in NASCAR that compares to turns one and two. It’s really important to hit your marks and be dialed in. We’ve had good speed in the past and good runs, our goal is to stay focused and get the best finish we can each race.”
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research, collaboration and quality manufacturing we strive to make life better for people affected by diabetes. We offer a wide range of therapies and a continued determination to provide real solutions—from medicines and technologies to support programs and more. For the latest updates, visit http://www.lillydiabetes.com/ or follow us on Twitter: @LillyDiabetes and Facebook: LillyDiabetesUS.
